LungÕ 2026 – Virtual Global Congress on Lung Oncology
ASTRIDE Bridges the Gap: Serplulimab Matches 32% Two-Year Survival in U.S. Patients with Small Cell Lung Cancer
Daniel Malarek and a Wish for Oncology: A Future Where Breakthroughs Reach Every Patient
London Global Cancer Week 2026: Highlights From November 2–4
Expert Discussion at COGC 2026: The Right First Investments in Precision Oncology
From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer
Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR
BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma
Celebrating its 20th landmark edition, the 20th International p53 Workshop arrives in Toronto from April 27 to May 1, 2026, to explore the frontier of the most frequently mutated gene in human cancer. Co-organized by Canada’s leading research powerhouses—University Health Network (UHN), the Lunenfeld-Tanenbaum Research Institute, and SickKids—this globally recognized summit gathers the world’s elite […]
The Community Oncology Conference 2026, organized by the Community Oncology Alliance (COA), will take place on April 28–29, 2026, at the Walt Disney World Dolphin Resort in Lake Buena Vista, Florida, USA. As the leading annual event for the field, the conference's core focus is equipping community oncologists and their teams with the necessary knowledge […]
The Thoracic Oncology Group of Australasia (TOGA) will host the interactive webinar "Beyond the NGS Report" on Tuesday, April 28, 2026, from 6:30 pm to 8:00 pm AEDT. Specifically designed for medical oncologists practicing without immediate access to a molecular tumor board, this session provides a framework for navigating complex molecular pathology reports. Through real-world […]
The ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29, 2026, focused on translating the latest ESMO Clinical Practice Guidelines into clinical practice. Chaired by Andrea Necchi, the webinar addresses the rapidly evolving landscape of bladder cancer management, including the integration of immune […]
The ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care conference is an interdisciplinary scientific meeting scheduled for April 29–30, 2026, in Houston, Texas. Organized by The University of Texas MD Anderson Cancer Center, the symposium focuses on optimizing oncological care by aligning medical treatments with individual patient values, preferences, and goals. The program […]
Closing out Head and Neck Cancers Awareness Month, the How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit addresses a disease group responsible for over 890,000 new annual diagnoses and 450,000 deaths. The program bridges the gap between emerging clinical evidence and real-world practice for early-stage, locally advanced, and recurrent/metastatic disease. The […]
The 2026 Highlights of ASH in Latin America is a two-day program scheduled for May 1–2, 2026, in Bogotá, Colombia, at the Grand Hyatt Bogotá. Organized by the American Society of Hematology (ASH) in collaboration with the Colombian Association of Hematology and Oncology (ACHO), the meeting is designed for hematologists, oncologists, and related professionals to […]
The APPOS Washington DC 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference tailored for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, as well as the entire multidisciplinary oncology team. The event is scheduled for May 1–2, 2026, and will be held at the Hyatt Regency Washington on Capitol […]
The 13th Cholangiocarcinoma Foundation Annual Conference, with the theme "Strength in Community: Every Patient Counts," will take place from May 1–3, 2026, in Salt Lake City, Utah. The event is hosted by the Cholangiocarcinoma Foundation and will convene a global community of leading researchers, clinicians, patients, caregivers, and advocates. Its purpose is to explore the […]
The Cancer Care and Prevention Symposium 2026, presented by Ironwood Cancer and Research Centers and Horizon CME, is a multidisciplinary conference scheduled for May 2, 2026, at The Westin Kierland Resort in Scottsdale, Arizona. The symposium is designed for a broad audience of healthcare professionals, including primary care providers and various oncologists, to discuss the […]
ANCO's Hematologic Malignancies Update 2026, held May 2–3, 2026, at the Hyatt Regency Monterey, will provide clinicians, nurses, nurse practitioners, and physician assistants with the latest advances in the treatment of hematologic malignancies. The two-day meeting features expert-led sessions on clinically relevant topics to support evidence-based practice in hematology and oncology.
The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6, 2026. This session focuses on the clinical management of high-risk localized prostate cancer, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji, the program features technical […]
The 6th ELRIG Advances in Cell-based Screening 2026 is a free-to-attend, two-day scientific conference scheduled for May 6–7, 2026, in Gothenburg, Sweden. Hosted at the AstraZeneca R&D site, this interactive event brings together biologists and chemists from academia and industry to explore the latest advancements in cell-based assays. The technical program focuses on state-of-the-art screening […]
Join the global breast cancer community at ESMO Breast Cancer 2026, taking place from 6 to 8 May 2026 in Berlin, Germany, or online. This international congress will gather top experts, researchers, and clinicians to explore the latest advances in breast cancer care, covering everything from early detection to innovative treatments and survivorship strategies. The […]
The public meeting, "Unlocking Next-Generation Therapies," is an event co-hosted by Friends of Cancer Research and the Parker Institute for Immunotherapy (PICI), scheduled for Wednesday, May 6, 2026, from 10:00 AM to 2:00 PM ET. Held at The Ritz-Carlton in Washington, DC, with a virtual option, the meeting will gather experts to explore innovative approaches […]
NCCN will host a specialized program titled "Optimizing Patient Outcomes - When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia" on May 6, 2026, from 3:00 PM to 4:00 PM EDT. Because conventional chemotherapy often yields poor responses in Richter transformation (RT), this session focuses on the critical […]
